Diana Kurmangali

Ms. Diana Kurmangali

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2025 in Foods
Verified
Journal Article
Open access
PDF file
GAGulyaim Abitayeva
Gulyaim Abitayeva
DKDiana Kurmangali
Diana Kurmangali
TBTemirlan Baikonys
Temirlan Baikonys
ZBZhandarbek Bekshin
Zhandarbek Bekshin
In this study, we conducted a whole-genome analysis of the Lacticaseibacillus paracasei subsp. paracasei 2LB isolated from Kazakh traditional fermented milk (koumiss) to identify genes associated with the safety and probiotic potential of the strain. A comparative genomic analysis of the core and pan-genome of L. paracasei 2LB was performed. Functional annotation revealed the presence of genes putatively involved in metabolism, genetic information processing, and cellular processes. In terms of safety parameters, the stability of its genetic material, the absence of the ability to synthesize virulence factors, and genes responsible for antibiotic resistance were characterized. Also, in vitro studies of the L. paracasei 2LB strain showed resistance to stress factors and antimicrobial activity, and the presence of coding sequences encoding adhesion factors, bacteriocins, bile salts, pH, cold and heat shock, and osmotic stress was observed through genomic analysis. These results indicate that the L. paracasei 2LB strain is a potential probiotic candidate and demonstrate that whole-genome analysis is a useful method for assessing the quality and safety of probiotics.

18 June 2026 in Data in Brief
Verified
Journal Article
Open access
DKDiana Kurmangali
Diana Kurmangali
GAGulyaim Abitayeva
Gulyaim Abitayeva
ZBZhandarbek Bekshin
Zhandarbek Bekshin
This study presents the high-quality draft genome sequence of Levilactobacillus brevis 3LB (L. brevis 3LB), a strain derived from a fermented milk koumiss from the Akmola region of the Republic of Kazakhstan. This strain is stored in the National Depository of Kazakhstan, Republican Collection of Microorganisms LLP, under the identifier L. brevis 3LB B-RKM 0546. Genomic DNA sequencing was performed on the Illumina MiSeq platform, and de novo genome assembly was carried out using SPAdes Genome Assembler v3.15.5. The assembled draft genome was 2307,466 bp in size, with 150x coverage, a GC content of 46.01%, an L50 value of 7, and an N50 value of 168,338 bp. The genome consists of 63 contigs and contains 2260 coding genes, as well as 61 transfer RNA (tRNA) genes, 7 ribosomal RNA (rRNA) genes, and 2 CRISPR loci. Functional analysis of the 3LB strain genome revealed the dominance of genes related to metabolism, information storage and processing, and cellular processes, providing a comprehensive understanding of the biological potential of bacteria by elucidating their biochemical reactions, metabolic pathways, and mechanisms of adaptation to the environment. According to GO analysis, these categories contain the highest number of genes (786, 549, and 361, respectively). Among the COG functional categories, transcription (228), translation and ribosome biogenesis (166), and carbohydrate metabolism (166) stand out. Cellular motility was the least represented (8 genes). KEGG analysis also confirmed the dominance of metabolism (446) and genetic information processing (296). RAST annotation further emphasized the importance of carbohydrate metabolism (19.82%), protein synthesis (16.37%), and amino acid synthesis (9.85%). CAZymes analysis identified 52 genes encoding enzymes involved in carbohydrate modification, with glycoside hydrolases (26) and glycosyltransferases (20). A genomic safety analysis of the L. brevis 3LB strain revealed that it is not a human pathogen, as it does not contain virulence genes, and the probability of structural pathogenicity is extremely low (0.0314). Although three incomplete phage regions and genes with low identity to vanT and nimA (requiring further study) were detected in silico, no known antibiotic resistance genes were detected. The absence of plasmids also confirms its safety. Notably, the strain possesses two high-fidelity CRISPR arrays, providing protective mechanisms. Furthermore, three secondary metabolite regions capable of synthesizing compounds with potential antibacterial activity (a class IV lanthanide peptide, a terpene precursor, and a polyketide) were identified, giving the strain a competitive advantage. These genome mining results indicate the biotechnological significance, safety, and probiotic potential of the novel strain L. brevis 3LB. The data presented here provide a foundation for further research into the probiotic activity of strain 3LB, both in vitro and in vivo, as well as its potential applications in food industry and biomedicine.

31 August 2025 in Journal of Health Development
Verified
Journal Article
Open access
ZBZhandarbek Bekshin
Zhandarbek Bekshin
ААА.м. Аскаров
А.м. Аскаров
DKDiana Kurmangali
Diana Kurmangali
AAAinur Amantayeva
Ainur Amantayeva
ДЖД.ш. Жакенов
Д.ш. Жакенов
ГБГ.н. Бисенова
Г.н. Бисенова
This article discusses the epidemiological situation of the global problem associated with the spread of tuberculosis in neighboring countries and in the Republic of Kazakhstan. The World Health Organization (WHO) is actively working on its elimination, aiming to reduce morbidity, mortality and financial costs associated with tuberculosis. According to the forecasts of the United Nations within the framework of the Tuberculosis Elimination Strategy and Sustainable Development Goals, the tuberculosis epidemic is expected to be eliminated by 2030. To achieve these goals, it is essential to monitor progress in the implementation of the plans, identify problem areas, and evaluate the effectiveness of the measures taken to eliminate tuberculosis. To date, tuberculosis remains one of the main infectious diseases in the countries of Eurasia, where historically complex epidemiological prerequisites have been formed. This study analyzes the dynamics of the spread of the disease in the period from 2019 to 2023, identifies key risk factors and substantiates the importance of creating comprehensive measures aimed at reducing the incidence of the disease. Kazakhstan and its neighboring countries (Russia, China, Uzbekistan, Kyrgyzstan and Turkmenistan), constitute a region with heterogeneous tuberculosis incidence rates, which is explained by a combination of socio-economic, geographical and medical factors. One of the factors influencing the spread of tuberculosis is the growing number of migrants in transit countries with border areas of Kazakhstan. According to the WHO, countries near Kazakhstan with economically high-income economies and steadily developing medical infrastructure such as Russia and China, have demonstrated improvement in the epidemiological situation of tuberculosis morbidity. However, despite declining incidence and availability of effective treatment, the incidence of tuberculosis in Kazakhstan and neighboring countries remains high and requires the introduction of a comprehensive approach of preventive measures, early diagnosis, application of advanced treatment methods, and raising public awareness. The main objective of this study is to assess the epidemiological situation in Kazakhstan and in geographically close countries.

19 October 2022 in Vestnik
Verified
Journal Article
Open access
ААА.ж. Ахметова
А.ж. Ахметова
ACAyaulym Chamoieva
Ayaulym Chamoieva
DKDiana Kurmangali
Diana Kurmangali
AAAinur Rakhmetulovna Akilzhanova
Ainur Rakhmetulovna Akilzhanova
UKUlan Kozhamkulov
Ulan Kozhamkulov
Қазақстанда туберкулез мәселесі әлі күнге дейін өзекті болып қалуда. Жылдан жылға дәріге-төзімді туберкулез формаларымен ауру деңгейінің жоғарылауы – аталған аурумен күресте негізгі мәселелердің бірі. Қазақстан дүниежүзінде туберкулезге қарсы қолданылатын ең тиімді бірінші қатардағы препараттар – изониазид пен рифампицинмен ассоциацияланған көптік дәріге төзімді туберкулез көрсеткіштері жоғары отыз мемлекеттер қатарына кіреді. Жұмыстың мақсаты MIRU-VNTR әдісін пайдалана отырып, Қазақстанда таралған туберкулездің қайталанған жағдайларының арасында M. tuberculosis клиникалық изоляттарының биологиялық әртүрлілігін бағалау болып табылады. Аталған зерттеу жұмысында рецидивтердің арасында 79 M. tuberculosis клиникалық изоляттары жиналды. M. tuberculosis клиникалық үлгілерін генотиптеу 12 MIRU локустары бойынша өткізілді. Барлық 12 локустың ПТР-амплификациясы реакцияға 5М бетаин қосу арқылы жүзеге асырылды. ПТР-өнімдері бромистік этидиймен боялған 1,5% агароздық гельде бөлінді. Содан кейін MIRU локустарындағы қайталанулар саны есептелді және әрбір M. tuberculosis клиникалық изолятына 12 саннан тұратын сандық профиль алынды. Жиналған M. tuberculosis клиникалық изоляттарының тұқымдастары MIRU-VNTRplus.org мәліметтер базасы көмегімен анықталды. Генотиптеу нәтижелері қайталанылған туберкулез жағдайларының арасында 88,6% (n=70) изоляттар Beijing тұқымдасына жататынын көрсетті. В Казахстане проблема туберкулеза остается актуальной. С каждым годом увеличивается уровень заболеваемости лекарственно-устойчивыми формами туберкулеза, что является главной преградой в борьбе с данным заболеванием. Казахстан является одной из тридцати стран в мире с высоким показателем туберкулеза с множественной лекарственной устойчивостью ассоциированного с лекарственной устойчивостью к самым эффективным противотуберкулезным препаратам первого ряда – изониазиду и рифампицину. Цель данной работы заключается в оценке биологического разнообразия клинических изолятов M. tuberculosis среди рецидивов в Казахстане с использованием MIRU-VNTR метода. В данном исследовании было собрано 79 клинических образцов M. tuberculosis среди повторных случаев туберкулеза из разных областей Казахстана. Генотипирование собранных клинических изолятов было проведено по 12 MIRUлокусам. ПЦР-амплификация всех 12 локусов была выполнена с добавлением в реакцию 5М бетаина. Разделение ПЦР-продуктов было проведено на 1,5% агарозном геле. Далее проводился подсчет тандемных повторов в MIRU локусах и был получен 12-ти значный цифровой профиль для каждого образца. M. tuberculosisсемейства собранных клинических изолятов были определены с помощью базы данных MIRU-VNTRplus.org. Результаты генотипирования показали, что 88,6% (n=70) изолятов среди рецидивов были отнесены к семейству Beijing. Tuberculosis still remains one of the important health issues in Kazakhstan. Extension of the incidence of drug-resistant forms every year is the main obstacle in the fight against the disease. Kazakhstan is one of the thirty countries on the planet with high rates of mulridrug-resistant tuberculosis associated with resistance to the most effective first-line antituberculosis drugs – isoniazid and rifampicin. Aim of this research is to evaluate biological diversity of clinical isolates of M. tuberculosis among recurrent tuberculosis cases in Kazakhstan by MIRU-VNTR method. 79 clinical isolates of M. tuberculosis were gathered from the patients with recurrent tuberculosis. Genotyping of the clinical samples was conducted by 12 MIRU loci. PCR amplification of 12 loci was done by addition of 5M betaine solution. PCR products were visualized on 1,5% agarose gel. Tandem repeats in the loci were calculated and the digital profile for every sample was obtained. M. tuberculosis families of the gathered clinical isolates were determined using...